Pacheco Patricia, Vieira-de-Abreu Adriana, Gomes Rachel N, Barbosa-Lima Giselle, Wermelinger Leticia B, Maya-Monteiro Clarissa M, Silva Adriana R, Bozza Marcelo T, Castro-Faria-Neto Hugo C, Bandeira-Melo Christianne, Bozza Patricia T
Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
J Immunol. 2007 Dec 15;179(12):8500-8. doi: 10.4049/jimmunol.179.12.8500.
Lipid bodies (also known as lipid droplets) are emerging as inflammatory organelles with roles in the innate immune response to infections and inflammatory processes. In this study, we identified MCP-1 as a key endogenous mediator of lipid body biogenesis in infection-driven inflammatory disorders and we described the cellular mechanisms and signaling pathways involved in the ability of MCP-1 to regulate the biogenesis and leukotriene B4 (LTB4) synthetic function of lipid bodies. In vivo assays in MCP-1-/- mice revealed that endogenous MCP-1 produced during polymicrobial infection or LPS-driven inflammatory responses has a critical role on the activation of lipid body-assembling machinery, as well as on empowering enzymatically these newly formed lipid bodies with LTB4 synthetic function within macrophages. MCP-1 triggered directly the rapid biogenesis of distinctive LTB4-synthesizing lipid bodies via CCR2-driven ERK- and PI3K-dependent intracellular signaling in in vitro-stimulated macrophages. Disturbance of microtubule organization by microtubule-active drugs demonstrated that MCP-1-induced lipid body biogenesis also signals through a pathway dependent on microtubular dynamics. Besides biogenic process, microtubules control LTB4-synthesizing function of MCP-1-elicited lipid bodies, in part by regulating the compartmentalization of key proteins, as adipose differentiation-related protein and 5-lipoxygenase. Therefore, infection-elicited MCP-1, besides its known CCR2-driven chemotactic function, appears as a key activator of lipid body biogenic and functional machineries, signaling through a microtubule-dependent manner.
脂滴(也称为脂质小体)正逐渐成为炎症细胞器,在对感染和炎症过程的固有免疫反应中发挥作用。在本研究中,我们确定单核细胞趋化蛋白-1(MCP-1)是感染驱动的炎症性疾病中脂滴生物合成的关键内源性介质,并描述了MCP-1调节脂滴生物合成和白三烯B4(LTB4)合成功能的细胞机制和信号通路。在MCP-1基因敲除小鼠中的体内实验表明,在多微生物感染或脂多糖驱动的炎症反应过程中产生的内源性MCP-1,对脂滴组装机制的激活以及赋予巨噬细胞内这些新形成的脂滴LTB4合成功能起着关键作用。在体外刺激的巨噬细胞中,MCP-1通过CCR2驱动的ERK和PI3K依赖性细胞内信号传导直接触发独特的LTB4合成脂滴的快速生物合成。微管活性药物对微管组织的干扰表明,MCP-1诱导的脂滴生物合成也通过依赖于微管动力学的途径发出信号。除了生物合成过程,微管还控制MCP-1诱导的脂滴的LTB4合成功能,部分是通过调节关键蛋白质(如脂肪分化相关蛋白和5-脂氧合酶)的区室化来实现的。因此,感染引发的MCP-1除了其已知的CCR2驱动的趋化功能外,还似乎是脂滴生物合成和功能机制的关键激活剂,通过微管依赖的方式发出信号。